Families of trans children are worried they may lose access to hormone blockers – despite the drugs being life-savers. The way Britain’s National Health Service cares for trans teens is about to undergo a judicial review.
In particular, the case targets hormone blockers which can delay puberty for young trans people. But those bringing the case say children can not give informed consent to the treatment.